Cargando…

Modulatory Effect of Vitamin C on Hypoxia Induced Breast Cancer Stem Cells

PURPOSE: Eliminating cancer stem cells (CSCs) is a challenge because of their enhanced resistance to anti-cancer drugs. Vitamin C, which is insufficient in patients with higher stages of cancer, has been gaining attention as a potential treatment for human malignancies. Hence this study aimed to ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemi, Masoumeh, Montazersaheb, Soheila, Noroozpour, Mina, Farajnia, Safar, Nozad Charoudeh, Hojjatollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676544/
https://www.ncbi.nlm.nih.gov/pubmed/38022819
http://dx.doi.org/10.34172/apb.2023.073
Descripción
Sumario:PURPOSE: Eliminating cancer stem cells (CSCs) is a challenge because of their enhanced resistance to anti-cancer drugs. Vitamin C, which is insufficient in patients with higher stages of cancer, has been gaining attention as a potential treatment for human malignancies. Hence this study aimed to analyze the effect of high-dose vitamin C treatment on the gene expression level of HIF-1α, NF-κB1, BAX, and DNMT1 in the MCF7 cells undergoing hypoxia, as an inducer of CSCs characteristics. As a result, vitamin C could be possibly used as a promising therapeutic adjuvant. METHODS: Here we first analyzed the breast CSC population alteration in MCF7 cells following hypoxia induction. Then, we evaluated the impact of vitamin C treatment on the gene expression level of four stemness-related genes in hypoxic MCF7 cells. RESULTS: Our results indicate that vitamin C could reduce proliferation and stemness states in CSCs possibly by induction of apoptotic markers such as BAX, along with attenuating stemness markers, including NF-κB1, and DNMT1 gene expressions. CONCLUSION: According to our findings, vitamin C administration would become a new approach to avoiding the stimulation of CSCs during cancer therapies.